Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
about
Nutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatmentAlloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive ImmunotherapyNK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseAdvantages and clinical applications of natural killer cells in cancer immunotherapyAdoptive cell therapy for sarcomaMembrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsTrends and advances in tumor immunology and lung cancer immunotherapyPhase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancerHypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunitySuccessful "in-flight" activation of natural killer cells during long-distance shippingNK cell-based immunotherapy for malignant diseases.Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCGMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.Molecular imaging of cell-based cancer immunotherapy.Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cellsAntioxidant bioavailability and rapid immune-modulating effects after consumption of a single acute dose of a high-metabolite yeast immunogen: results of a placebo-controlled double-blinded crossover pilot studyMetabolic perturbation sensitizes human breast cancer to NK cell-mediated cytotoxicity by increasing the expression of MHC class I chain-related A/BPresent and Future of Allogeneic Natural Killer Cell TherapyPancreatic ductal adenocarcinoma: a review of immunologic aspects.Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.Cellular and molecular immunology of lung cancer: therapeutic implications.Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.Potential clinical applications for human pluripotent stem cell-derived blood components.Natural killer cell lines in tumor immunotherapy.Natural killer cells: a review of manufacturing and clinical utility.NK cells: key to success of DC-based cancer vaccines?At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Human NK cells: from surface receptors to the therapy of leukemias and solid tumorsAdoptive immunotherapy against sarcomas.Natural killer cells as helper cells in dendritic cell cancer vaccines.Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.NK cell-based cancer immunotherapy: from basic biology to clinical application.
P2860
Q26753067-E2BEDA20-E3B4-4A28-8BB8-0C0CEC7029E0Q26777209-B955BE14-2C54-4933-8A32-AE902B9E1A47Q26863559-23AC4B53-31CC-4BF0-A0A6-30ADA2DC832DQ26996330-CB9B7601-555D-45A0-BDF3-E4FC30DD6004Q26999224-8DF80AF1-4FA9-4D0F-9A7E-5FD50757D6A3Q27009541-86217C6B-2016-4C6C-83FE-37F179977138Q27309991-785DD8CE-7AA4-4440-A232-689DA0CC8A0DQ28067674-F47BF4E2-EE43-4F21-B406-E935FAE4A16BQ28266580-30F5784D-3169-437D-AC19-A2A5835DE4FDQ31118586-A2856E48-898A-408A-BF58-9D3028D485A2Q33700795-021A8EBD-5051-4024-BE2A-C025DBB19D2EQ33787299-6CE18F3A-4827-4B86-8627-CC9F8E8D84A8Q33827433-527C620D-2F71-4D85-B323-11AF88336F35Q33940675-76FCE649-8A18-4AFF-BA0F-8AB2B7A4BC96Q34551581-72240B80-30DE-4487-9463-B36028737B06Q34563034-31EA60DD-80B5-4457-81FF-701BEB77CBADQ34717870-62726E99-3977-4EC9-9F13-D838257B60C2Q34934718-C1C77F2B-CA88-44EF-A2CE-FC6BFD736D4EQ35168325-3DBC1379-2F92-415A-82A6-85004969E71EQ35506699-FE99BD69-D933-4CF0-A20A-5A3249B8FF6CQ35677351-6A286CEB-114D-4760-97B9-3DF5EE91E765Q35870682-38CF8288-A97A-4D52-9DED-FE683BFEC9E4Q35903264-2170C653-EF6E-47D9-A8B9-978619655C9EQ36130505-DC2DF589-9D9C-42DC-9210-2FC4485C3CC9Q36856792-0144FD05-9960-4BC2-941B-420CCB8AB8DDQ37122377-0B838985-0B8D-4640-915F-C0D157DB83EEQ37141296-2CF802B6-5094-4EE3-AE78-38DBED6E9E66Q37155165-7F9D9433-6F50-4BDF-BF51-EED1941E7D84Q37178190-B03F22BA-0E5C-41C9-88D8-AE55EC154B4DQ37857709-E35FB163-AD1B-4F35-8CB2-9DD55182288FQ37998371-853F00FB-1258-4E90-86EE-5CEA4106793FQ38016470-A34E2077-B7F1-4DF8-8179-811D2A81E943Q38036202-4A2BAB04-7B7F-48C6-8A8F-2C7FDF5FC256Q38151057-BF2F31DB-3C1F-4EEC-8DD2-D5D104381689Q38196803-20F7AB2A-E606-4637-B45B-3EB8C1C97E79Q38291193-7D6A01C9-4872-45FD-B7E5-C0EEEBB9B7A5Q38352462-F4FBA7EA-E41B-4472-A469-54BFCA8BDFA1Q38544057-212D6D08-5D9F-4E71-994A-48769B48EFA2Q38599353-C853AF1F-2A70-4A54-A672-D0418C7CD08EQ38640489-2BAD64B0-86F4-4BB6-A1C8-B35AE4015B95
P2860
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@en
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@nl
type
label
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@en
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@nl
prefLabel
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@en
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@nl
P2860
P1476
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
@en
P2860
P304
P356
10.1111/J.1365-2796.2009.02121.X
P407
P577
2009-08-01T00:00:00Z